Patents by Inventor Gayatri Sathyan

Gayatri Sathyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
    Patent number: 11786505
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including mycophenolate sodium, in canine subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders, and immune rejection related to transplant or graft procedures.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: October 17, 2023
    Assignee: Okava Pharmaceuticals, Inc.
    Inventors: Michael Klotsman, Padmaja Shivanand, Wayne H. Anderson, Gayatri Sathyan
  • Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
    Patent number: 11633378
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including sodium mycophenolate, in veterinary subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders associated with IMPDH activity, and immune rejection related to transplant or graft procedures.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: April 25, 2023
    Assignee: Okava Pharmaceuticals, Inc.
    Inventors: Michael Klotsman, Padmaja Shivanand, Wayne H. Anderson, Gayatri Sathyan
  • Method of administering amantadine prior to a sleep period
    Patent number: 11197835
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 14, 2021
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20200237686
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: December 26, 2019
    Publication date: July 30, 2020
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS
    Publication number: 20200030285
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including sodium mycophenolate, in veterinary subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders associated with IMPDH activity, and immune rejection related to transplant or graft procedures.
    Type: Application
    Filed: March 13, 2018
    Publication date: January 30, 2020
    Inventors: Michael KLOTSMAN, Padmaja SHIVANAND, Wayne H. ANDERSON, Gayatri SATHYAN
  • METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS
    Publication number: 20190201375
    Abstract: The present disclosure provides methods and compositions for modified delivery of mycophenolic acid active agents, including mycophenolate sodium, in canine subjects. Presently disclosed methods and compositions are useful, for example, to treat autoimmune diseases, blood disorders, and immune rejection related to transplant or graft procedures.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 4, 2019
    Inventors: Michael KLOTSMAN, Padmaja SHIVANAND, Wayne H. Anderson, Gayatri SATHYAN
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20180263928
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 20, 2018
    Applicant: Adamas Pharma, LLC
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • Method of administering amantadine prior to a sleep period
    Patent number: 9877933
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 30, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Method of administering amantadine prior to a sleep period
    Patent number: 9867792
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Method of administering amantadine prior to a sleep period
    Patent number: 9867791
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • Method of administering amantadine prior to a sleep period
    Patent number: 9867793
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: January 16, 2018
    Assignee: Adamas Pharma, LLC
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151183
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151186
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151185
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151184
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151187
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170151190
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Inventors: Gregory T. WENT, Gayatri SATHYAN, Kavita VERMANI, Gangadhara GANAPATI, Michael COFFEE, Efraim SHEK, Ashok KATDARE
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20160263056
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20160263053
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare
  • AMANTADINE COMPOSITIONS AND METHODS OF USE
    Publication number: 20160263055
    Abstract: Methods of nighttime administration of amantadine to reduce sleep disturbances in patient undergoing treatment with amantadine are described, as well as compositions of extended release amantadine that are suitable for nighttime administration.
    Type: Application
    Filed: September 23, 2015
    Publication date: September 15, 2016
    Inventors: Gregory T. Went, Gayatri Sathyan, Kavita Vermani, Gangadhara Ganapati, Michael Coffee, Efraim Shek, Ashok Katdare